Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…
Biotechnology and pharmaceuticals
Novo Nordisk's first GLP-1 obesity pill launched in the US
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, on November…
FDA approves first GLP-1 obesity pill from Wegovy maker Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, outside Copenhagen, Denmark, on…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Pfizer's 2026 guidance shows deals with Metsera and Seagen will take time to bear fruit
Smith Collection | Stock Photos | fake images Pfizer It forecast modest guidance for 2026 on Tuesday as it looks…
Eli Lilly's Anti-Obesity Pill Maintains Weight Loss After Wegovy, Zepbound
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
UnitedHealth Group Releases Independent Audit Results
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…
Anti-obesity pills from Novo Nordisk and Eli Lilly arrive
Daniel Grill tetra images | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…